Autoimmune pancreatitis is a rare form of chronic pancreatitis characterized by focal or diffuse swelling of the pancreas, irregular narrowing of the main pancreatic duct, hyperglobulinemia, presence of autoantibodies, and marked response to corticosteroid therapy. Patients with autoimmune pancreatitis often have dilatation of the common bile duct without dilatation of the main pancreatic duct. Contrast-enhanced harmonic gray-scale ultrasound has recently been used to evaluate the vascularity of pancreatic mass lesions; it can visualize blood perfusion in pancreatic mass lesions without producing motion artifacts. Patients with pancreatic carcinoma and autoimmune pancreatitis were required to hold their breath from 20 to 50 seconds after administration of Levovist
® (Schering AG, Berlin, Germany) or Sonazoid
® (GE Healthcare, Oslo, Norway) while the vascularity (tumor vessels and tumor enhancement) of the lesion was examined by contrast-enhanced harmonic gray-scale ultrasound (early phase). Lesion enhancement was monitored for about 90 to 180 seconds after the injection with patients holding their breath for several seconds (delayed phase). Although pancreatic carcinoma lesions exhibited some grade of tumor vessels, autoimmune pancreatic lesions showed no apparent tumor vessels in the early phase. Almost all pancreatic carcinoma lesions showed positive enhancement only in the peripheral tumor region; however, autoimmune pancreatitis lesions exhibited enhancement throughout the entire lesion in both the early and delayed phases. Grade of lesion vascularity in the contrast-enhanced harmonic gray-scale ultrasonograms correlated directly with pathologic grade of inflammation and inversely with grade of fibrosis associated with autoimmune pancreatitis lesions. Lesion vascularity had decreased on contrast-enhanced harmonic gray-scale ultrasonograms after steroid therapy. Contrast-enhanced harmonic gray-scale ultrasound was useful in evaluating vascularity of autoimmune pancreatitis lesion and may prove useful in the differential diagnosis between pancreatic carcinoma and autoimmune pancreatitis.
View full abstract